Lazard Asset Management LLC Shockwave Medical, Inc. Transaction History

Lazard Asset Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$191.17 - $325.63 $1.25 Million - $2.14 Million	-6,557 Reduced 22.25%	22,911 $7.46 Million
Q4 2023 Feb 14, 2024	BUY	$160.99 - $215.69 $427,267 - $572,441	2,654 Added 9.9%	29,468 $5.62 Million
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $1.53 Million - $2.24 Million	7,886 Added 41.66%	26,814 $5.34 Million
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $63,346 - $85,961	284 Added 1.52%	18,928 $5.4 Million
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $2.66 Million - $3.31 Million	15,168 Added 436.36%	18,644 $4.04 Million
Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $8,175 - $11,872	40 Added 1.16%	3,476 $714,000
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $464,599 - $739,061	2,380 Added 225.38%	3,436 $954,000
Q2 2022 Aug 09, 2022	SELL	$115.91 - $214.48 $435,357 - $805,586	-3,756 Reduced 78.05%	1,056 $201,000
Q1 2022 May 13, 2022	BUY	$127.96 - $207.36 $314,653 - $509,898	2,459 Added 104.5%	4,812 $997,000
Q4 2021 Feb 09, 2022	BUY	$165.13 - $241.83 $6,770 - $9,915	41 Added 1.77%	2,353 $418,000
Q3 2021 Nov 15, 2021	BUY	$163.99 - $235.57 $379,144 - $544,637	2,312 New	2,312 $475,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.